Back
Kiniksa Pharmaceuticals Stock Price Chart
Sponsored
Your Chance To Invest In The Green Energy Revolution!
Don't miss this one - click for more info and ADD THIS COMPANY TO YOUR WATCHLIST!
Buy
56
KNSA
Kiniksa Pharmaceuticals
Last Price:
14.16
Seasonality Move:
-5.39%
7 Day Trial
ALL ACCESS PASS
$
7
Sponsored
New Year, New Trades, Try A.I. Today
Learn to forecast trends with up to 87.4% proven accuracy -> Register Here- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KNSA is experiencing slight buying pressure.
Kiniksa Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.07 | Buy |
| 20-day SMA: | 14.45 | Buy |
| 50-day SMA: | 15.17 | Sell |
| 200-day SMA: | 12.1 | Buy |
| 8-day EMA: | 14.21 | Buy |
| 20-day EMA: | 14.41 | Buy |
| 50-day EMA: | 14.57 | Sell |
| 200-day EMA: | 13.12 | Buy |
Kiniksa Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.26 | Sell |
| Relative Strength Index (14 RSI): | 50.01 | Buy |
| Chaikin Money Flow: | 52521 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14 - 15.1) | Sell |
| Bollinger Bands (100): | (12.28 - 15.72) | Buy |
Kiniksa Pharmaceuticals Technical Analysis
| Jan-19 | Jan-20 | Jan-23 | Jan-24 | Jan-25 | Jan-26 | Jan-27 | Jan-30 | Jan-31 | Feb-1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 19 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Kiniksa Pharmaceuticals Stock
Is Kiniksa Pharmaceuticals Stock a Buy?
- Kiniksa Pharmaceuticals share price is 14.52 while KNSA 8-day simple moving average is 14.07, which is a Buy signal.
- The stock price of KNSA is 14.52 while Kiniksa Pharmaceuticals 20-day SMA is 14.45, which makes it a Buy.
- Kiniksa Pharmaceuticals 50-day simple moving average is 15.17 while KNSA share price is 14.52, making it a Sell technically.
- KNSA stock price is 14.52 and Kiniksa Pharmaceuticals 200-day simple moving average is 12.10, creating a Buy signal.
KNSA Technical Analysis vs Fundamental Analysis
Buy
56
Kiniksa Pharmaceuticals (KNSA)
is a Buy
Is Kiniksa Pharmaceuticals a Buy or a Sell?
-
Kiniksa Pharmaceuticals stock is rated a Buy
The current Kiniksa Pharmaceuticals [KNSA] share price is $14.52. The Score for KNSA is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
Kiniksa Pharmaceuticals Stock Info
Market Cap:
1.01B
Price in USD:
14.52
Share Volume:
367.65K
Kiniksa Pharmaceuticals 52-Week Range
52-Week High:
17.20
52-Week Low:
7.36
Buy
56
Kiniksa Pharmaceuticals (KNSA)
is a Buy
Kiniksa Pharmaceuticals Share Price Forecast
-
What is the Kiniksa Pharmaceuticals stock price today?
The Kiniksa Pharmaceuticals stock price is 14.52 USD today. -
Will KNSA stock go up or go down?
Kiniksa Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Kiniksa Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Kiniksa Pharmaceuticals is not overvalued.
Is Kiniksa Pharmaceuticals Stock a Buy?
- Kiniksa Pharmaceuticals share price is 14.52 while KNSA 8-day exponential moving average is 14.21, which is a Buy signal.
- The stock price of KNSA is 14.52 while Kiniksa Pharmaceuticals 20-day EMA is 14.41, which makes it a Buy.
- Kiniksa Pharmaceuticals 50-day exponential moving average is 14.57 while KNSA share price is 14.52, making it a Sell technically.
- KNSA stock price is 14.52 and Kiniksa Pharmaceuticals 200-day simple moving average is 13.12, creating a Buy signal.
Fundamental Analysis of Kiniksa Pharmaceuticals
Is Kiniksa Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.53 per share, and a decrease next year of $0.33 per share.
Technical Analysis of Kiniksa Pharmaceuticals
Should I short Kiniksa Pharmaceuticals stock?
- KNSA Moving Average Covergence Divergence (MACD) indicator is -0.26, suggesting Kiniksa Pharmaceuticals is a Sell
- Kiniksa Pharmaceuticals Relative Strength Index (RSI) is 50.01, which suggest Kiniksa Pharmaceuticals is overbought
- The Bollinger Bands (25) for Kiniksa Pharmaceuticals is (14 - 15.1), which suggest Kiniksa Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Kiniksa Pharmaceuticals is (12.28 - 15.72), which suggest Kiniksa Pharmaceuticals is a Buy
* Kiniksa Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.